Erratum

Erratum for the Research Article: “The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study” by P. Kiessling, R. Lledo-Garcia, S. Watanabe, G. Langdon, D. Tran, M. Bari, L. Christodoulou, E. Jones, G. Price, B. Smith, F. Brennan, I. White, S. Jolles

See allHide authors and affiliations

Science Translational Medicine  06 Dec 2017:
Vol. 9, Issue 419, eaar6448
DOI: 10.1126/scitranslmed.aar6448

Article Information

vol. 9 no. 419

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
    Other Contributors: 
    • American Association for the Advancement of Science

    Author Information

    Altmetric

    Article usage

    Article usage: December 2017 to October 2018

    AbstractFullPdf
    Dec 2017029000
    Jan 201801240
    Feb 20180770
    Mar 20180620
    Apr 20180670
    May 201801010
    Jun 20180600
    Jul 20180500
    Aug 201801040
    Sep 20180640
    Oct 20180620

    Navigate This Article